Impact of COVID-19 on patients with atopic dermatitis

Data on the tolerability and response to biologic therapies for type 2 immune disorders in the context of coronavirus disease 2019 (COVID-19) are currently lacking. Our survey aimed at assessing the adherence of patients to dupilumab therapy and the risk of the severe acute respiratory syndrome coro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Dermatol
Autores principales: Grieco, Teresa, Chello, Camilla, Sernicola, Alvise, Muharremi, Rovena, Michelini, Simone, Paolino, Giovanni, Carnicelli, Giorgia, Pigatto, Paolo Daniele
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Inc. 2021
Materias:
COVID-19: Important updates and developments
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285243/
https://ncbi.nlm.nih.gov/pubmed/34920828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clindermatol.2021.07.008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares